These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17873709)

  • 41. Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.
    Sparshatt A; Taylor D; Patel MX; Kapur S
    Acta Psychiatr Scand; 2009 Dec; 120(6):416-28. PubMed ID: 19573049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.
    Ilett KF; Watt F; Hackett LP; Kohan R; Teoh S
    Ther Drug Monit; 2010 Dec; 32(6):704-7. PubMed ID: 20926994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract]   [Full Text] [Related]  

  • 44. [Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
    Krähenmann R; Küchenhoff B; Böker H; Schick M
    Psychiatr Prax; 2010 Sep; 37(6):306-9. PubMed ID: 20803411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deconstructing a medication regimen.
    Preskorn SH
    J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
    [No Abstract]   [Full Text] [Related]  

  • 46. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 48. Prandial effect on the systemic exposure of amisulpride.
    Jang YJ; Jeong TC; Noh K; Baek IW; Kwon KI; Kim E; Yoon YR; Kang W
    Arch Pharm Res; 2014 Oct; 37(10):1325-8. PubMed ID: 24469600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.
    Martina AC; Ee JS; Lamberti JS
    Schizophr Res; 2019 Aug; 210():308-309. PubMed ID: 31277977
    [No Abstract]   [Full Text] [Related]  

  • 50. Disposition of enantiomers of sultopride in a human, rats and rabbits.
    Kamizono A; Inotsume N; Fukushima S; Nakano M
    Biol Pharm Bull; 1993 Nov; 16(11):1121-3. PubMed ID: 7906175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders.
    Varol Tas F; Guvenir T
    Eur Child Adolesc Psychiatry; 2009 Aug; 18(8):511-3. PubMed ID: 19267176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Affective Recurrences in Bipolar Disorder After Switching From Lithium to Valproate or Vice Versa: A Series of 57 Cases.
    Rosso G; Solia F; Albert U; Maina G
    J Clin Psychopharmacol; 2017 Apr; 37(2):278-281. PubMed ID: 28129310
    [No Abstract]   [Full Text] [Related]  

  • 53. Amisulpride augmentation of clozapine in refractory schizophrenia.
    Chiu HW; Ku YC; Li TC; Huang HT
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E15. PubMed ID: 21948906
    [No Abstract]   [Full Text] [Related]  

  • 54. Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.
    Pavuluri MN; Lee MS; Pandey G
    Bipolar Disord; 2015 Mar; 17(2):224-32. PubMed ID: 25523965
    [No Abstract]   [Full Text] [Related]  

  • 55. Lithium treatment of trichotillomania with comorbid bipolar II disorder.
    Sharma V; Corpse C
    Arch Womens Ment Health; 2008 Sep; 11(4):305-6. PubMed ID: 18677437
    [No Abstract]   [Full Text] [Related]  

  • 56. Olanzapine-associated Edema Decreasing Serum Lithium Concentrations: A Case Report.
    Cusimano J; Martin C; VandenBerg A
    J Clin Psychopharmacol; 2020; 40(5):499-500. PubMed ID: 32858619
    [No Abstract]   [Full Text] [Related]  

  • 57. Amisulpride monotherapy may be a choice of maintenance treatment for patients with both bipolar I disorder and metabolic syndrome.
    Hong CC; Chen CK; Yeh TC; Chu CS; Chen TY
    Aust N Z J Psychiatry; 2015 Aug; 49(8):757-8. PubMed ID: 25788497
    [No Abstract]   [Full Text] [Related]  

  • 58. Noninvasive lithium monitoring.
    Préat V
    Clin Chem; 2004 Nov; 50(11):1966-7. PubMed ID: 15502077
    [No Abstract]   [Full Text] [Related]  

  • 59. Recommencing lithium in Older Adults with Bipolar I Disorder.
    Gallur L; Powell A; Flynn P
    Australas Psychiatry; 2017 Dec; 25(6):571-573. PubMed ID: 29087206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fatal intoxication with amisulpride and presentation of organ distribution].
    Musshoff F; Kröner L; Padosch SA; Madea B
    Arch Kriminol; 2005; 215(5-6):158-63. PubMed ID: 15991733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.